Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Longitudinal Investigation of Cortical Demyelination and Meningeal Inflammation in Multiple Sclerosis and Related Disorders
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Procedures mentioned: MRI scans
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "In this protocol, a combination of MRI, blood, and cerebrospinal fluid (CSF) analysis will be used to understand the natural history, underlying immunologic mechanisms, and clinical implications of central nervous system (CNS) lesions, in particular lesions in the cerebral cortex, in multiple sclerosis (MS) and other inflammatory and autoimmune disorders affecting the CNS."
- "Patients with these disorders, as well as healthy controls, will undergo baseline clinical evaluation and testing, bloodwork, and MRI, with follow up clinical evaluation, bloodwork, and MRI at years 1, 3, and 6."
- "Additional MRIs may be performed in patients with possible new lesion formation or to compare MRI techniques."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study uses MRI scans, blood tests, and sometimes spinal fluid tests to learn how damage in the brain and spinal cord changes over time. It is for people with multiple sclerosis (MS) or other diseases involving inflammation or an immune system attack on the brain and spinal cord, and for healthy volunteers. Follow-up visits are planned at years 1, 3, and 6.
In this protocol, a combination of MRI, blood, and cerebrospinal fluid (CSF) analysis will be used to understand the natural history, underlying immunologic mechanisms, and clinical implications of central nervous system (CNS) lesions, in particular lesions in the cerebral cortex, in multiple sclerosis (MS) and other inflammatory and autoimmune disorders affecting the CNS. Patients with these disorders, as well as healthy controls, will undergo baseline clinical evaluation and testing, bloodwork, and MRI, with follow up clinical evaluation, bloodwork, and MRI at years 1, 3, and 6. Additional MRIs may be performed in patients with possible new lesion formation or to compare MRI techniques. Lumbar puncture will be performed on participants who are not currently being treated with disease modifying therapies and who are willing to undergo the procedure.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 18, as stated in the study listing.
- Able to understand and agree to join the study in English.
- Able to have an MRI scan.
Who can't join
- Have a condition or other reason that makes an MRI scan unsafe.
- Are pregnant.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * 18 years old * able to provide consent in English * able to undergo MRI Exclusion Criteria: * contraindication to MRI * pregnancy
Study sites (1)
NY
- Mount Sinai Hospital · New York, NY 10029Erin S Beck, MD, PhD · Study contact · 212-241-2474 · erin.beck@mssm.eduJulia L Galasso, BS · Study contact · 212-241-9463 · julia.galasso@mssm.eduErin S Beck · Principal investigatorMore trials in New York